Urshila Durani, M.D., M.P.H.

  1. Hematologist
  2. Internist
  3. Oncologist

Departments

Location

  1. Rochester, Minnesota

Languages

English

Urshila Durani, M.D., M.P.H., is a board-certified hematologist with a specialty interest in lymphoma, stem cell (bone marrow) transplant, and cellular therapy. Her clinical focus includes:

  • Use of allogeneic and autologous stem cell (bone marrow) transplant for the treatment of lymphoma
  • Use of chimeric antigen receptor T-cell therapy for the treatment of lymphoma
  • Management of both Hodgkin and non-Hodgkin lymphoma

In addition to her clinical interests, Dr. Durani is active in research focused on cancer care delivery, survivorship and health outcomes. She also had an interest in medical trainee education and development.

  1. Bone marrow transplant
  2. CAR t-cell therapy
  1. 2021
    Advanced Fellowship - Hematopoietic Cell Transplant and Cellular Therapy City of Hope National Medical Center
  2. 2020
    Fellowship - Hematology and Medical Oncology Mayo Clinic School of Graduate Medical Education
  3. 2017
    Residency - Internal MedicineMayo Clinic School of Graduate Medical Education
  4. 2014
    MDNorthwestern University Feinberg School of Medicine
  5. 2014
    MPHNorthwestern University Feinberg School of Medicine
  6. 2010
    BA - Anthropology Honors Program in Medical EducationNorthwestern University

Certifications

  1. 2020
    HematologyAmerican Board of Internal Medicine
  2. 2020
    Medical OncologyAmerican Board of Internal Medicine
  3. 2017
    Internal MedicineAmerican Board of Internal Medicine

Awards and honors

  1. 2020
    Angela and Anne V. Marinelli Endowed FellowshipMayo Clinic
  2. 2020
    Tow Tan Humanism in Medicine AwardMayo Clinic
  3. 2020
    Outstanding Hematology-Oncology TraineeMayo Clinic
  4. 2019
    Chief FellowMayo Clinic in Rochester
  5. 2018
    Outstanding Fellow Award The Minnesota Society of Clinical Oncology

Professional memberships

  1. 2020 - 2021
    Task forceAmerican Society of Hematology
  2. 2017 - present
    MemberAmerican Society of Clinical Oncology

Publications